Child health at two years corrected age after antenatal exposure to dexamethasone or betamethasone; a randomised trial

对有早产风险的妇女给予地塞米松或倍他米松，可大大改善新生儿和儿童的健康。关于地塞米松是否优于倍他米松，有相互矛盾的报道。这项随机试验将评估这一点。如果地塞米松是更有益的，将有更少的死亡和残疾儿童。这对于澳大利亚和国际上面临早产风险的妇女、她们的孩子以及医疗服务的护理至关重要。

Both dexamethasone or betamethasone, given to women at risk of preterm birth substantially improve neonatal and child health. There are conflicting reports as to whether dexamethasone is better than betamethasone? This randomised trial will assess this. If dexamethasone is more beneficial, there will be fewer deaths and fewer disabled children. This will be of great importance for the care of women at risk of preterm birth, their children and health services in Australia and internationally.